Various ecological groups have issued statements in recent days, expressing their concern over the possible creation of a “seed monopoly” in the country’s agriculture sector, should the General Assembly approve a controversial new law proposal, now making the rounds during the closing days of Ecuador’s current government.
“…There is pressure for this law to be passed, with these proposals being in favor of creating a seed monopoly which will restrict and affect the free sale of these products, harming small-scale farmers.” said José Rivadeneira, spokesman for the Coordinadora Ecuatoriana de Agroecología (Ecuador Agro-ecology Coordinator). In their view, these ‘pressures’ can be traced to major companies such as Monsanto “who are trying to control the entire production” of grains such as rice and corn – a view that has set off several alarm bells among rural communities worldwide.
The global market for seeds and agro-chemicals was shaken in recent weeks with the revelation of German powerhouse Bayer’s intentions to purchase leading GMO seed makers Monsanto. The deal is expected to create a globe-spanning behemoth, capable of altering the entire market and supply chain for a number of vital industries.
MIguel Carvajal, from the Alianza PAIS parliamentary group and president of the Assembly’s Commission for Food Sovereignty, agreed that “there are many weak spots, many faults in the law.” However, he was clear in saying the debate is not yet finalized: “This law seeks to develop better conditions,so Ecuador may push forward the production of seeds and carry out research to improve our handling of our native seeds, and the community and private companies that are in charge of them.”
Full Content: La Hora
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Subscribers Defend $4.7 Billion Antitrust Verdict Against NFL in Court Filings
Jul 19, 2024 by
CPI
Von der Leyen Calls for Competition Policy to Boost EU Companies’ Growth
Jul 19, 2024 by
CPI
Vermont AG Sues Pharmacy Benefit Managers Over Drug Prices
Jul 18, 2024 by
CPI
Australians Face Increased Stamp Prices Following ACCC Approval
Jul 18, 2024 by
CPI
Live Nation Seeks Dismissal of DOJ Antitrust Allegations
Jul 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Private Equity Roll-Up Schemes
Jun 28, 2024 by
CPI
The FTC’s Focus on Private Equity is Warranted
Jun 28, 2024 by
CPI
Unraveling the Roll-Up: Private Equity’s Misunderstood Investment Strategy
Jun 28, 2024 by
CPI
Antitrust Focus on Private Equity Funds and Serial Acquisitions
Jun 28, 2024 by
CPI
Private Equity Roll-Ups Amidst Heightened Antitrust Enforcement
Jun 28, 2024 by
CPI